Atlanta – September 21, 2026 -- Georgia Power and Google have filed a new agreement with the Georgia Public Service Commission that ties Google's subscription to nuclear capacity uprates at Plants Hatch and Vogtle, a move projected to deliver approximately $900 million in customer benefits over the life of the units.

Washington – September 21, 2026 -- The Teamsters Union has endorsed a settlement agreement announced by California Attorney General Rob Bonta that clears a path for the pending merger between Paramount Skydance and Warner Bros. Discovery.

Seattle – September 21, 2026 -- Glacis Technologies has agreed to transfer stewardship of OVERT, its open technical specification for verifying AI safeguards at runtime, to the Coalition for Health AI (CHAI) and the AIGovOps Foundation.

Waltham, Mass. – September 21, 2026 -- The U.S. Food and Drug Administration has approved Mercy BioAnalytics' Investigational Device Exemption application for its Evident Ovarian Cancer Screening Test, clearing the way for the company's pivotal SOARA Clinical Validation Study pending Institutional Review Board sign-off.

Idaho Falls – September 21, 2026 -- Construction projects in Eastern Idaho frequently require a stack of approvals beyond the standard building permit, including well permits, septic system reviews, driveway access clearances, utility connection permits, and floodplain reviews, according to insights from Ren Ferguson of Copper Creek Homes published by HelloNation.

Jerusalem – September 21, 2026 -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has regained compliance with Nasdaq's $1.00 minimum bid price rule after its American Depositary Shares closed at or above that threshold for 19 consecutive business days, Nasdaq Listing Qualifications confirmed in a September 18, 2026 letter.

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.

Germantown, Md. – September 21, 2026 -- The U.S. Food and Drug Administration has granted platform technology designation to Precigen's AdenoVerse immunotherapeutic platform, the technology underlying the company's first commercial product, PAPZIMEOS, approved in August 2025 for recurrent respiratory papillomatosis (RRP) in adults.

New Taipei City – September 21, 2026 -- UD info's DB Series SSD Drives have achieved FIPS 140-3 validation from the National Institute of Standards and Technology's Cryptographic Module Validation Program, with NIST Certificate No. 5479 issued August 12, 2026, confirming Overall Level 2 status.

Beijing – September 20, 2026 -- Chinese President Xi Jinping has ordered sustained expansion of advanced manufacturing, calling for smart, green and integrated industrial upgrading to strengthen supply-chain self-sufficiency, according to instructions conveyed at a national conference on advanced manufacturing in Beijing reported by Xinhua News Agency.